Search results for PX-TA1360
Showing 1 – 10 of1products

ID: BAB992949117
Lenzilumab Biosimilar – Anti-CSF2 mAb – Research Grade, ProteoGenix, PX-TA1360
Description of Lenzilumab Biosimilar - Anti-CSF2 mAb - Research Grade General information on Anti-CSF2[Homo sapiens] (Lenzilumab) Monoclonal Antibody Lenzilumab is investigated for the treatment of Chronic Myelomonocytic Leukemia (CMML).
Host
Reactivity
Applications
Conjugation
Request a product
Please provide the required information below so that we can quickly source your products.
